Footnotes

• Twitter @IBDdoc

• Contributors All authors contributed to the preparation of this manuscript.

• Funding JE was funded by the National Institute for Health Research Oxford Biomedical Research Centre.

• Competing interests JE served on the clinical advisory board for Lumendi and Boston Scientific and the clinical advisory board and ownership for Satisfai Health; and received speaker fees from Falk. CJR received grant funding from ARC Medical, Norgine Pharmaceuticals UK, Olympus Medical UK, 3D Matrix and was an expert witness for ARC Medical. BH received grant funding from Olympus Medical UK, Fujifilm Europe, Takeda Pharmaceuticals UK and AbbVie UK, and served on the clinical advisory board and ownership of Ampersand Health, Surgease Medical Ltd.

• Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

• Patient consent for publication Not required.

• Provenance and peer review Not commissioned; externally peer reviewed.

• Data availability statement There are no data in this work.